DILLARDS INC-CL A (DDS) Fundamental Analysis & Valuation

NYSE:DDS • US2540671011

630.94 USD
+19.14 (+3.13%)
At close: Mar 4, 2026
630.94 USD
0 (0%)
After Hours: 3/4/2026, 8:19:25 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DDS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall DDS gets a fundamental rating of 6 out of 10. We evaluated DDS against 30 industry peers in the Broadline Retail industry. Both the health and profitability get an excellent rating, making DDS a very profitable company, without any liquidiy or solvency issues. DDS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. DDS Profitability Analysis

1.1 Basic Checks

  • DDS had positive earnings in the past year.
  • DDS had a positive operating cash flow in the past year.
  • Of the past 5 years DDS 4 years were profitable.
  • Each year in the past 5 years DDS had a positive operating cash flow.
DDS Yearly Net Income VS EBIT VS OCF VS FCFDDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.51%, DDS belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
  • DDS has a better Return On Equity (28.40%) than 93.33% of its industry peers.
  • DDS has a better Return On Invested Capital (19.86%) than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DDS is significantly above the industry average of 9.25%.
  • The 3 year average ROIC (28.72%) for DDS is well above the current ROIC(19.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.51%
ROE 28.4%
ROIC 19.86%
ROA(3y)21.67%
ROA(5y)17.85%
ROE(3y)44.12%
ROE(5y)37.36%
ROIC(3y)28.72%
ROIC(5y)N/A
DDS Yearly ROA, ROE, ROICDDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.77%, DDS is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • DDS's Profit Margin has improved in the last couple of years.
  • DDS's Operating Margin of 10.56% is fine compared to the rest of the industry. DDS outperforms 73.33% of its industry peers.
  • DDS's Operating Margin has improved in the last couple of years.
  • DDS's Gross Margin of 40.22% is on the low side compared to the rest of the industry. DDS is outperformed by 66.67% of its industry peers.
  • DDS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.56%
PM (TTM) 8.77%
GM 40.22%
OM growth 3Y-13.46%
OM growth 5Y33.93%
PM growth 3Y-11.56%
PM growth 5Y38.75%
GM growth 3Y-2.28%
GM growth 5Y4.06%
DDS Yearly Profit, Operating, Gross MarginsDDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DDS Health Analysis

2.1 Basic Checks

  • DDS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, DDS has less shares outstanding
  • The number of shares outstanding for DDS has been reduced compared to 5 years ago.
  • DDS has a better debt/assets ratio than last year.
DDS Yearly Shares OutstandingDDS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DDS Yearly Total Debt VS Total AssetsDDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 7.33 indicates that DDS is not in any danger for bankruptcy at the moment.
  • DDS's Altman-Z score of 7.33 is amongst the best of the industry. DDS outperforms 96.67% of its industry peers.
  • The Debt to FCF ratio of DDS is 0.67, which is an excellent value as it means it would take DDS, only 0.67 years of fcf income to pay off all of its debts.
  • DDS has a better Debt to FCF ratio (0.67) than 86.67% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that DDS is not too dependend on debt financing.
  • DDS has a Debt to Equity ratio of 0.21. This is in the better half of the industry: DDS outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.67
Altman-Z 7.33
ROIC/WACC2.2
WACC9.01%
DDS Yearly LT Debt VS Equity VS FCFDDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.19 indicates that DDS has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.19, DDS is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
  • DDS has a Quick Ratio of 1.00. This is a normal value and indicates that DDS is financially healthy and should not expect problems in meeting its short term obligations.
  • DDS has a Quick ratio of 1.00. This is in the lower half of the industry: DDS underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1
DDS Yearly Current Assets VS Current LiabilitesDDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DDS Growth Analysis

3.1 Past

  • DDS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.17%.
  • The Earnings Per Share has been growing by 57.80% on average over the past years. This is a very strong growth
  • DDS shows a decrease in Revenue. In the last year, the revenue decreased by -1.07%.
  • DDS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.77% yearly.
EPS 1Y (TTM)-5.17%
EPS 3Y-5.24%
EPS 5Y57.8%
EPS Q2Q%7.5%
Revenue 1Y (TTM)-1.07%
Revenue growth 3Y-0.17%
Revenue growth 5Y0.77%
Sales Q2Q%2.74%

3.2 Future

  • Based on estimates for the next years, DDS will show a decrease in Earnings Per Share. The EPS will decrease by -4.48% on average per year.
  • DDS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.33% yearly.
EPS Next Y-8.36%
EPS Next 2Y-6.39%
EPS Next 3Y-4.48%
EPS Next 5YN/A
Revenue Next Year1.54%
Revenue Next 2Y1.26%
Revenue Next 3Y1.33%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DDS Yearly Revenue VS EstimatesDDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
DDS Yearly EPS VS EstimatesDDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

4

4. DDS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.13, the valuation of DDS can be described as rather expensive.
  • Based on the Price/Earnings ratio, DDS is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.03. DDS is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 19.52, DDS is valued on the expensive side.
  • DDS's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of DDS to the average of the S&P500 Index (25.11), we can say DDS is valued slightly cheaper.
Industry RankSector Rank
PE 17.13
Fwd PE 19.52
DDS Price Earnings VS Forward Price EarningsDDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DDS indicates a somewhat cheap valuation: DDS is cheaper than 70.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, DDS is valued a bit cheaper than 63.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.61
EV/EBITDA 10.1
DDS Per share dataDDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

  • The excellent profitability rating of DDS may justify a higher PE ratio.
  • A cheap valuation may be justified as DDS's earnings are expected to decrease with -4.48% in the coming years.
PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2Y-6.39%
EPS Next 3Y-4.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DDS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.20%, DDS is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.62, DDS pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.20, DDS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

  • On average, the dividend of DDS grows each year by 111.67%, which is quite nice.
  • DDS has paid a dividend for at least 10 years, which is a reliable track record.
  • DDS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)111.67%
Div Incr Years14
Div Non Decr Years34
DDS Yearly Dividends per shareDDS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

  • DDS pays out 71.18% of its income as dividend. This is not a sustainable payout ratio.
  • DDS's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.18%
EPS Next 2Y-6.39%
EPS Next 3Y-4.48%
DDS Yearly Income VS Free CF VS DividendDDS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B
DDS Dividend Payout.DDS Dividend Payout, showing the Payout Ratio.DDS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DDS Fundamentals: All Metrics, Ratios and Statistics

DILLARDS INC-CL A

NYSE:DDS (3/4/2026, 8:19:25 PM)

After market: 630.94 0 (0%)

630.94

+19.14 (+3.13%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-13
Earnings (Next)05-11
Inst Owners69.76%
Inst Owner Change0.35%
Ins Owners23.17%
Ins Owner Change-1.62%
Market Cap9.85B
Revenue(TTM)6.63B
Net Income(TTM)580.86M
Analysts45.45
Price Target572.56 (-9.25%)
Short Float %9.67%
Short Ratio4.86
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend25.75
Dividend Growth(5Y)111.67%
DP71.18%
Div Incr Years14
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.62%
Min EPS beat(2)22.99%
Max EPS beat(2)34.25%
EPS beat(4)4
Avg EPS beat(4)26.67%
Min EPS beat(4)12.59%
Max EPS beat(4)36.84%
EPS beat(8)7
Avg EPS beat(8)17.05%
EPS beat(12)11
Avg EPS beat(12)23.25%
EPS beat(16)15
Avg EPS beat(16)42.18%
Revenue beat(2)2
Avg Revenue beat(2)2.1%
Min Revenue beat(2)1.59%
Max Revenue beat(2)2.62%
Revenue beat(4)3
Avg Revenue beat(4)1.63%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)2.94%
Revenue beat(8)5
Avg Revenue beat(8)0.34%
Revenue beat(12)7
Avg Revenue beat(12)0.47%
Revenue beat(16)11
Avg Revenue beat(16)1.52%
PT rev (1m)0%
PT rev (3m)30.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.19%
EPS NY rev (1m)0%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)-1.16%
Revenue NQ rev (3m)1.38%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE 17.13
Fwd PE 19.52
P/S 1.49
P/FCF 12.61
P/OCF 11.31
P/B 4.82
P/tB 4.82
EV/EBITDA 10.1
EPS(TTM)36.84
EY5.84%
EPS(NY)32.32
Fwd EY5.12%
FCF(TTM)50.05
FCFY7.93%
OCF(TTM)55.77
OCFY8.84%
SpS424.44
BVpS131.01
TBVpS131.01
PEG (NY)N/A
PEG (5Y)0.3
Graham Number329.54
Profitability
Industry RankSector Rank
ROA 13.51%
ROE 28.4%
ROCE 24.53%
ROIC 19.86%
ROICexc 37.32%
ROICexgc 37.32%
OM 10.56%
PM (TTM) 8.77%
GM 40.22%
FCFM 11.79%
ROA(3y)21.67%
ROA(5y)17.85%
ROE(3y)44.12%
ROE(5y)37.36%
ROIC(3y)28.72%
ROIC(5y)N/A
ROICexc(3y)44.45%
ROICexc(5y)N/A
ROICexgc(3y)44.45%
ROICexgc(5y)N/A
ROCE(3y)35.47%
ROCE(5y)N/A
ROICexgc growth 3Y-15.2%
ROICexgc growth 5Y43.2%
ROICexc growth 3Y-15.2%
ROICexc growth 5Y43.2%
OM growth 3Y-13.46%
OM growth 5Y33.93%
PM growth 3Y-11.56%
PM growth 5Y38.75%
GM growth 3Y-2.28%
GM growth 5Y4.06%
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.67
Debt/EBITDA 0.49
Cap/Depr 50.64%
Cap/Sales 1.35%
Interest Coverage 250
Cash Conversion 99.36%
Profit Quality 134.5%
Current Ratio 2.19
Quick Ratio 1
Altman-Z 7.33
F-Score5
WACC9.01%
ROIC/WACC2.2
Cap/Depr(3y)64.95%
Cap/Depr(5y)54.93%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.64%
Profit Quality(3y)99.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.17%
EPS 3Y-5.24%
EPS 5Y57.8%
EPS Q2Q%7.5%
EPS Next Y-8.36%
EPS Next 2Y-6.39%
EPS Next 3Y-4.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.07%
Revenue growth 3Y-0.17%
Revenue growth 5Y0.77%
Sales Q2Q%2.74%
Revenue Next Year1.54%
Revenue Next 2Y1.26%
Revenue Next 3Y1.33%
Revenue Next 5YN/A
EBIT growth 1Y-8.1%
EBIT growth 3Y-13.61%
EBIT growth 5Y34.96%
EBIT Next Year29.84%
EBIT Next 3Y4.59%
EBIT Next 5YN/A
FCF growth 1Y10.49%
FCF growth 3Y-19.67%
FCF growth 5Y18.42%
OCF growth 1Y4%
OCF growth 3Y-17.68%
OCF growth 5Y14.36%

DILLARDS INC-CL A / DDS FAQ

What is the fundamental rating for DDS stock?

ChartMill assigns a fundamental rating of 6 / 10 to DDS.


Can you provide the valuation status for DILLARDS INC-CL A?

ChartMill assigns a valuation rating of 4 / 10 to DILLARDS INC-CL A (DDS). This can be considered as Fairly Valued.


How profitable is DILLARDS INC-CL A (DDS) stock?

DILLARDS INC-CL A (DDS) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for DDS stock?

The Price/Earnings (PE) ratio for DILLARDS INC-CL A (DDS) is 17.13 and the Price/Book (PB) ratio is 4.82.


How sustainable is the dividend of DILLARDS INC-CL A (DDS) stock?

The dividend rating of DILLARDS INC-CL A (DDS) is 5 / 10 and the dividend payout ratio is 71.18%.